Over the coming months, we will be analysing data from all patients diagnosed with pediatric differentiated thyroid carcinoma (ped-DTC) between 1 January 2020 and 31 December 2023. This year, we aim to publish our first article reporting on these patients, providing a comprehensive overview of the landscape of ped-DTC across Europe. The findings will offer valuable insights into disease characteristics, treatment patterns, and outcomes, helping to guide future care and research for children with thyroid cancer.
